Region

Australia only  

Brief summary

Obesity can increase the risk of developing MS and may increase levels of disability in those with established MS. Losing weight can help improve more than just body size, but it can be difficult to do and needs the support of a healthcare team to aid behaviour change. This study will use a tested method to help people with MS make healthier choices in their eating patterns, exercise routine, and overall self-management to aid in weight management. 

The study will include adults with relapsing-remitting MS who are overweight (Body Mass Index (BMI) >25kg/m2 and <40kg/m2). Participants will be randomly assigned to either standard care (exercise and nutrition advice from a nurse) or a personalised plan (nutrition, exercise, and psychological support from an Accredited Practising Dietitian). The study will last for six months, followed by another six months follow up to see if the positive changes are sustained in the longer-term. This study will be delivered via telehealth. 

The study will look at weight loss and improvements in symptoms like fatigue, sleep, disability, and quality of life. It will also evaluate the cost benefits. It is hypothesised that the personalised approach will lead to more weight loss and better symptom management for the participants. 

Click here (or to the button on the left) to access our pre-screen eligibility survey and a member from our research team will be in contact. 

This study has received University of Wollongong Human Research Ethics Approval (UOW HREC #2024/164) and it is registered with the Australia New Zealand Clinical Trial Registry (ACTRN12625000578404).

Anticipated Start Date

Currently recruiting